Study shows new drug helps 'bridge' stent patients to cardiac surgery

New findings from a research study led by physicians at Scripps Health reveal that the drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications.

Read the whole article on Physorg

More from Physorg